Another example where big tech and biology are blurring the lines.
Sanofil is a target of Verily, an Alphabet Division (Google 2.0) – and they may have a nifty nanobot cure for diabetes.
Read more
Verily, Alphabet and Google Look to Cure Diabetes – With Nanobots?
Posted in biotech/medical, nanotechnology